SICAGENBSESicagen India LtdMediumNeutral
Announced Mon, 12 May · 15:57 IST

Appointment/Re-appointment of Internal Auditor, Cost Auditor & Secretarial Auditor.

Management Changes View source PDF

SICAGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Sicagen India's Board, at its May 12, 2025 meeting, approved the audited financial results (standalone and consolidated) for Q4 and FY ending March 31, 2025, with the auditors giving an unmodified (clean) opinion. The Board has recommended an equity dividend of 10% (Re.1 per share) for FY 2024-25, subject to shareholder approval at the upcoming AGM. KRA & Associates was appointed as Secretarial Auditor for a five-year term starting FY 2025-26. Sundar Srini & Sridhar was re-appointed as Internal Auditor and J. Karthikeyan & Associates as Cost Auditor for FY 2025-26, both subject to shareholder approval.

Likely market impact

The clean audit opinion and 10% dividend reflect stable financial health and reward shareholders for FY25, likely viewed positively by retail investors. Routine auditor re-appointments suggest continuity with no governance concerns.